Jan Wijnholds
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 24
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments 20
-
- Pharmacological Effects and Toxicity Studies 17
- Molecular Biology top 1%
- Retinal Development and Disorders 54
- Developmental Biology and Gene Regulation 14
- CRISPR and Genetic Engineering 13
- Cell Biology top 1%
- Hippo pathway signaling and YAP/TAZ 21
-
- Virus-based gene therapy research 11
- Co-authors
- Piet BorstRaymond EversMarcel KoolPeter R. WielingaMarcel de HaasJos H. BeijnenGlen ReidGeorge L. Scheffer
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Nucleic Acids Research (6 papers)Journal of Biological Chemistry (1 paper)
- Partner nations
- NetherlandsGermanyFrance
In The Last Decade
Jan Wijnholds
120 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 4.4k
- Ophthalmology 1.1k
- Pediatrics, Perinatology and Child Health 1.8k
- Molecular Biology 5.0k
- Cell Biology 1.1k
Countries citing papers authored by Jan Wijnholds
This map shows the geographic impact of Jan Wijnholds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Wijnholds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Wijnholds more than expected).
Fields of papers citing papers by Jan Wijnholds
This network shows the impact of papers produced by Jan Wijnholds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Wijnholds. The network helps show where Jan Wijnholds may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jan Wijnholds, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 2 | |
| 3 | 2021 | 11 | |
| 4 | 2021 | 28 | |
| 5 | 2020 | 63 | |
| 6 | 2020 | 19 | |
| 7 | 2019 | 16 | |
| 8 | 2019 | 30 | |
| 9 | 2018 | 30 | |
| 10 | 2018 | 25 | |
| 11 | 2018 | 44 | |
| 12 | Recapitulation of the Human Fetal Crumbs Complex in human iPSCs-derived Retinas and Retinal Pigment Epithelium | 2017 | 1 |
| 13 | 2017 | 76 | |
| 14 | 2015 | 49 | |
| 15 | CRB1 and CRB2 In Retinal Development - Part 1 | 2011 | 1 |
| 16 | 2008 | 60 | |
| 17 | 2005 | 138 | |
| 18 | Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance. | 2000 | 168 |
| 19 | The multidrug resistance protein familybreakdown → | 1999 | 525 |
| 20 | CC EBP, A CHICKEN TRANSCRIPTION FACTOR OF THE LEUCINE-ZIPPER C/EBP FAMILY | 1993 | 3 |
About Jan Wijnholds
Jan Wijnholds is a scholar working on Ophthalmology, Cell Biology and Molecular Biology, having authored 121 papers that have together received 10.0k indexed citations. Recurring topics across this work include Retinal Development and Disorders (54 papers), Drug Transport and Resistance Mechanisms (24 papers), Hippo pathway signaling and YAP/TAZ (21 papers), Retinal Diseases and Treatments (20 papers), Pharmacological Effects and Toxicity Studies (17 papers), Developmental Biology and Gene Regulation (14 papers), CRISPR and Genetic Engineering (13 papers) and Virus-based gene therapy research (11 papers). The work is most often cited by research in Oncology (4.4k citations), Ophthalmology (1.1k citations) and Pediatrics, Perinatology and Child Health (1.8k citations). Jan Wijnholds has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include Piet Borst, Raymond Evers, Marcel Kool, Peter R. Wielinga, Marcel de Haas, Jos H. Beijnen, Glen Reid, George L. Scheffer, Alfred H. Schinkel and Liesbeth van Deemter. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.